Literature DB >> 23149615

Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23149615     DOI： 10.1007/s00384-012-1610-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  5 in total

1.  Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.

Authors:  Tineke W H Meijer; Olga C J Schuurbiers; Johannes H A M Kaanders; Monika G Looijen-Salamon; Lioe-Fee de Geus-Oei; Ad F T M Verhagen; Jasper Lok; Henricus F M van der Heijden; Saskia E Rademakers; Paul N Span; Johan Bussink
Journal:  Lung Cancer       Date:  2011-12-06       Impact factor: 5.705

2.  Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.

Authors:  Byoung Yong Shim; Ji-Han Jung; Kang-Moon Lee; Hyung-Jin Kim; Sook Hee Hong; Sung Hwan Kim; Der Sheng Sun; Hyeon-Min Cho
Journal:  Int J Colorectal Dis       Date:  2012-07-31       Impact factor: 2.571

3.  [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].

Authors:  Bo Wei; Lin Chen; Jie Li
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2009-05

4.  Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.

Authors:  Sung Soo Kang; Yi Kyeong Chun; Min Hee Hur; Hae Kyung Lee; Yee Jeong Kim; Sung Ran Hong; Jee Hyun Lee; Sung Gong Lee; Yong Koo Park
Journal:  Jpn J Cancer Res       Date:  2002-10

5.  GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma.

Authors:  Fernanda Rocha Rojas Ayala; Rafael Malagoli Rocha; Kátia Cândido Carvalho; André Lopes Carvalho; Isabela Werneck da Cunha; Silvia Vanessa Lourenço; Fernando Augusto Soares
Journal:  Molecules       Date:  2010-04-01       Impact factor: 4.411
  5 in total
  2 in total

1.  α-Hederin inhibits the growth of lung cancer A549 cells in vitro and in vivo by decreasing SIRT6 dependent glycolysis.

Authors:  Cong Fang; Yahui Liu; Lanying Chen; Yingying Luo; Yaru Cui; Ni Zhang; Peng Liu; Mengjing Zhou; Yongyan Xie
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

2.  Glycosylation of anthocyanins enhances the apoptosis of colon cancer cells by handicapping energy metabolism.

Authors:  Nan Jing; Jiaxing Song; Zheng Liu; Luoyang Wang; Guoqiang Jiang
Journal:  BMC Complement Med Ther       Date:  2020-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.